What is Leucine?
Founded in 2019 and headquartered in Wilmington, Delaware, Leucine offers a no-code software solution designed to empower pharmaceutical manufacturers to become compliant and audit-ready. Its platform enables Manufacturing, QA, and QC teams to embed compliance by design across a multitude of complex, regulated workflows, from the initial receipt of materials to the final batch release. Globally, pharmaceutical manufacturing facilities leverage Leucine's solutions daily to elevate product quality, boost operational efficiency, and promote sustainability within their stringent regulatory environments. The company's focus on simplifying complex compliance processes through an intuitive, no-code interface positions it as a key player in the RegTech sector for the pharmaceutical industry.
How much funding has Leucine raised?
Leucine has raised a total of $7M across 1 funding round:
Series A
$7M
Series A (2023): $7M with participation from Ecolab
Key Investors in Leucine
Ecolab
Ecolab Inc. is a global leader in water, hygiene, and infection prevention solutions and services. Their Global Life Sciences segment specifically provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers, aligning with Leucine's focus on pharmaceutical compliance and operational efficiency.
What's next for Leucine?
The recent major strategic investment in Leucine signals a strong validation of its business model and market potential within the highly regulated pharmaceutical sector. This capital infusion is expected to fuel further development of its no-code compliance platform, potentially expanding its feature set to address an even broader spectrum of regulatory challenges. Leucine is likely to focus on enhancing its market penetration, forging new strategic partnerships, and scaling its customer support infrastructure to accommodate a growing global client base. The company's trajectory suggests a continued emphasis on innovation in compliance technology, aiming to become the de facto standard for pharmaceutical manufacturers seeking to streamline and secure their regulated workflows.
See full Leucine company page
